Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hatim Fakir

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Advances in Radiation Oncology|July 19, 2021
Can Polymetastatic Disease Be ARRESTed Using SABR? A Dosimetric Feasibility Study to Inform Development of a Phase 1 TrialMark T Corkum, Hatim Fakir, David A Palma, et al.
Journal of Theoretical Biology|September 28, 2007
Second cancers after fractionated radiotherapy: stochastic population dynamics effectsRainer K Sachs, Igor Shuryak, David Brenner, et al.
Radiation Protection Dosimetry|December 6, 2006
Alpha-hit, cellular dose, cell transformation and inactivation probability distributions of radon progenies in the bronchial epitheliumIstván Szoke, Imre Balásházy, Arpád Farkas, et al.
BMC Cancer|April 15, 2021
Ablative radiation therapy to restrain everything safely treatable (ARREST): study protocol for a phase I trial treating polymetastatic cancer with stereotactic radiotherapyGlenn S Bauman, Mark T Corkum, Hatim Fakir, et al.
Cureus|June 8, 2022
Dosimetric Planning Comparison for Left-Sided Breast Cancer Radiotherapy: The Clinical Feasibility of Four-Dimensional-Computed Tomography-Based Treatment Planning OptimizationOi-Wai Chau, Hatim Fakir, Michael Lock, et al.
Frontiers in Oncology|August 20, 2025
A proof-of-concept study of personalized dosimetry for targeted radioligand therapy using pre-treatment diagnostic dynamic PET/CT and Monte Carlo simulationThanh Tai Duong, Danny De Sarno, Hatim Fakir, et al.
Advances in Radiation Oncology|May 1, 2023
Planning for the Effect of the SC.24 Trial on Spine Stereotactic Body Radiation Therapy Utilization at a Tertiary Cancer CenterAndrew J Arifin, Sympascho Young, Glenn S Bauman, et al.
International Journal of Radiation Oncology, Biology, Physics|January 11, 2026
Practical Aspects of Delivering Radiation for Poly-metastatic DiseaseHatim Fakir, Gage Redler, Glenn S Bauman, et al.
Frontiers in Oncology|May 2, 2022
Imaging Biomarkers in Prostate Stereotactic Body Radiotherapy: A Review and Clinical Trial ProtocolWei Liu, Andrew Loblaw, David Laidley, et al.
Clinical and Translational Radiation Oncology|November 29, 2021
Defining radio-recurrent intra-prostatic target volumes using PSMA-targeted PET/CT and multi-parametric MRIWei Liu, Hatim Fakir, Gurpreet Randhawa, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Advances in Radiation Oncology|July 19, 2021
Can Polymetastatic Disease Be ARRESTed Using SABR? A Dosimetric Feasibility Study to Inform Development of a Phase 1 TrialMark T Corkum, Hatim Fakir, David A Palma, et al.
Journal of Theoretical Biology|September 28, 2007
Second cancers after fractionated radiotherapy: stochastic population dynamics effectsRainer K Sachs, Igor Shuryak, David Brenner, et al.
Radiation Protection Dosimetry|December 6, 2006
Alpha-hit, cellular dose, cell transformation and inactivation probability distributions of radon progenies in the bronchial epitheliumIstván Szoke, Imre Balásházy, Arpád Farkas, et al.
BMC Cancer|April 15, 2021
Ablative radiation therapy to restrain everything safely treatable (ARREST): study protocol for a phase I trial treating polymetastatic cancer with stereotactic radiotherapyGlenn S Bauman, Mark T Corkum, Hatim Fakir, et al.
Cureus|June 8, 2022
Dosimetric Planning Comparison for Left-Sided Breast Cancer Radiotherapy: The Clinical Feasibility of Four-Dimensional-Computed Tomography-Based Treatment Planning OptimizationOi-Wai Chau, Hatim Fakir, Michael Lock, et al.
Frontiers in Oncology|August 20, 2025
A proof-of-concept study of personalized dosimetry for targeted radioligand therapy using pre-treatment diagnostic dynamic PET/CT and Monte Carlo simulationThanh Tai Duong, Danny De Sarno, Hatim Fakir, et al.
Advances in Radiation Oncology|May 1, 2023
Planning for the Effect of the SC.24 Trial on Spine Stereotactic Body Radiation Therapy Utilization at a Tertiary Cancer CenterAndrew J Arifin, Sympascho Young, Glenn S Bauman, et al.
International Journal of Radiation Oncology, Biology, Physics|January 11, 2026
Practical Aspects of Delivering Radiation for Poly-metastatic DiseaseHatim Fakir, Gage Redler, Glenn S Bauman, et al.
Frontiers in Oncology|May 2, 2022
Imaging Biomarkers in Prostate Stereotactic Body Radiotherapy: A Review and Clinical Trial ProtocolWei Liu, Andrew Loblaw, David Laidley, et al.
Clinical and Translational Radiation Oncology|November 29, 2021
Defining radio-recurrent intra-prostatic target volumes using PSMA-targeted PET/CT and multi-parametric MRIWei Liu, Hatim Fakir, Gurpreet Randhawa, et al.
Pageof 3